Want to join the conversation?
$EMR expects 2Q16 underlying sales to decline about 4-6%, excluding negative currency translation and an impact from divestitures of about 2% each. Reported sales for 2Q16 are expected to be down about 8-10%. $EMR projects 2Q16 adjusted EPS of about $0.60-0.65, excluding about $75MM of separation costs, and reported EPS of $0.49-0.54.
$EXTR has been on an interesting uptrend, fundamentals kinda tricky but solid technical. Earnings 5th
Wow! $MCD scores again.